
Immunologist @Regeneron PhD @institutpasteur and @Neovacs opinions expressed here are my own.
Manhattan, NY
Joined January 2016
- Tweets106
- Following325
- Followers132
- Likes779
Pinned Tweet
Very happy to share some of the work that I have been doing during my PhD!! Paper is out in @NatureComms !! Thanks to all the authors that contributed to the work! @Neovacs @LReberLab @ImmunoPasteur
Our new paper describing the efficacy of a vaccine in asthma is out! Congratulations to Eva !! #vaccin #asthma @Inserm @Neovacs @evaconde06 nature.com/articles/s41467-0…
Delighted to share my postdoc work understanding the role of IL-33 on B cells and plasma cells. Thank you to all the authors that contributed!
nature.com/articles/s41467-0…
Eva Conde García retweeted
IL-33 expands plasma cells, disrupts germinal centers, and increases autoantibody production in mice
@NatureComms @evaconde06 @Regeneron
nature.com/articles/s41467-0…
Eva Conde García retweeted
An experimental vaccine against IgE induces neutralizing anti-IgE antibodies and protects against #anaphylaxis in humanized mice for as long as one year, supporting its potential as a long-term anti-allergy treatment. @evaconde06 @institutpasteur scim.ag/3M87zFP
Eva Conde García retweeted
Vaccine targeting human IgE induces long-term protection against anaphylaxis in humanized mice
science.org/doi/10.1126/scit… @evaconde06 @Neovacs @LReberLab
@INSERM
Commentaries:
nature.com/articles/d41586-0…
www-science-org.uc.idm.oclc.…
Eva Conde García retweeted
Science #Immunology's September issue is out!
This month's cover spotlights the unique properties of plasma cells that produce allergy-driving immunoglobulin E (#IgE). Other work looks at #Langerhans cell development, human #MAIT cells, and more.
scim.ag/8hd
Congrats Andrea and the team👏!! Check this out ! IgE plasma cells have unique characteristics that makes them so long lived and pathogenic.
New research in mice identifies the unique developmental timeline and transcriptional signatures of short-lived and long-lived #allergy-mediating #IgE plasma cells. @Regeneron
Learn more in Science #Immunology: scim.ag/8hf
Eva Conde García retweeted
How does vedolizumab work in ulcerative colitis patients?
Researchers in a new @SciImmunology study say the drug targets gut-associated lymphoid tissue. Learn more: scim.ag/6KJ
Eva Conde García retweeted
How does #vedolizumab work in ulcerative #colitis patients?
Researchers say the drug targets gut-associated lymphoid tissue. Learn more in a new study: scim.ag/6F1
Congratulations @pabloimmune and team!! Check this out! Great story and beautiful images!👏👏
Excited to share our new work in @SciImmunology! We describe targeting of gut-associated lymphoid tissue (GALT) as a novel mode of action of anti-α4β7 therapy in IBD. Co-led by @mat_uzz & A. Seki @MehandruLab @SinaiImmunol @MountSinaiGI @IcahnMountSinai🧵
science.org/doi/10.1126/scii…
Eva Conde García retweeted
Mientras alguien nos recuerda (Roca Editorial, 2023), de Carmen Conde Veiga es una novela que transporta a los lectores a la Barcelona de 1946, sumergiéndoles en una trama que se desenvuelve en el Instituto Mental de la Santa Cruz.
revista.espacio17musas.com/m…
Eva Conde García retweeted
A therapy based on a #BispecificAntibody and an IL-4R-alpha blocker reverses allergies in animals by depleting all plasma cells and selectively preventing reemergence of IgE-producing plasma cells, show findings in animals and a clinical trial. @Regeneron scim.ag/5cc
Eva Conde García retweeted
Our courageous postdoc research scientists deserve a strong first contract that expands housing access and meets their childcare needs. There is no research without the researchers.
Proud to stand with @spocuaw 💪🏽
Today is @spocuaw’s 7th day on the picket line, as the first postdoc researchers in the private sector to walk out on strike.
As @ShawnFainUAW said, “You produce scientific breakthroughs, so you deserve record gains. Groundbreaking research should mean groundbreaking contracts.”
Eva Conde García retweeted
We believe understanding core biology holds the key to answering fundamental truths about serious diseases. Our latest research explores a key driver of allergies and is the cover feature in Science Translational Medicine.
Eva Conde García retweeted
Don't miss this week's issue of #ScienceTranslationalMedicine!
New drug candidates could fill treatment gaps for neglected tropical diseases, an antibody therapy targets allergic memory to prevent allergic reactions in animals, and more. scim.ag/5bj
Eva Conde García retweeted
Gut IgA: Never fear, super inducers are here. @pabloimmune &Cerutti discuss @TStappenbeckMD work showing pectin-derived prebiotic enhanced IgA resp. to commensals. Effects involve Lachnospiraceae A2, showing a few symbionts promote IgA to many commensals cell.com/cell-host-microbe/f…
Eva Conde García retweeted
We wrote a Preview in @cellhostmicrobe to highlight work by Zhang, Han & @TStappenbeckMD on IgA induction by a select group of gut symbionts, aka the super inducers 💪
cell.com/cell-host-microbe/f…
Check this out! TRAPnSeq is a very useful technique developed at Regeneron that allows antigen-specific plasma cell sorting! Congratulations to Seble, Andrea and the team 👏
TRAPnSeq allows high-throughput profiling of antigen-specific antibody-secreting cells dlvr.it/SrrW3Y
Eva Conde García retweeted
When someone who has benefited from systemic privileges realizes the status quo is changing and the competition no longer includes only their favored demographic but people from all walks of life #meritocricy science.org/content/article/…





























